Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
QT Imaging Holdings, Inc. Common Stock(QTI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for QTI
09/16/2026: QTI (1-star) is currently NOT-A-BUY. Pass it for now.
QT Imaging Holdings is an early-stage medical technology company that provides the QTscan, a radiation-free, automated breast ultrasound system. The company's primary strength lies in its patient-friendly, proprietary technology that offers a non-invasive alternative to traditional imaging. Its growth potential depends heavily on successfully scaling installations and achieving broader clinical and insurance adoption. However, it faces significant risks including intense competition from well-capitalized imaging incumbents and the inherent challenges of commercializing a new diagnostic modality. The stock is best suited for growth-oriented investors with a high risk tolerance who are looking to monitor the company’s ability to execute on its commercialization pipeline and secure consistent healthcare market access.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers potential high growth in the medical imaging space but faces high execution and market adoption risks. |
| Momentum investor | Weak fit | The stock lacks the consistent trading volume and upward price trend typically required for a momentum strategy. |
| Value investor | Weak fit | The company is in an early commercial phase and does not currently fit traditional value metrics. |
| Dividend investor | Weak fit | The company does not pay a dividend and is focused on reinvesting capital. |
| Low-risk investor | Weak fit | High volatility and early-stage company risks make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to significant price swings due to low float and speculative nature. |
| Valuation risk | High | Early-stage commercialization makes it difficult to justify current valuations based on traditional cash flows. |
| Competition risk (Medical Imaging Giants) | High | The company must compete with established incumbents like Hologic and GE who control the majority of the market. |
| Business quality | Medium | The technology is innovative but the business model is still being proven at scale. |
| Dividend income | Low / none | There is no dividend income for investors. |
| Execution risk | High | Success depends on the company's ability to drive hospital adoption and secure favorable reimbursement. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit 68.01% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/16/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.47M USD | Price to earnings Ratio - | 1Y Target Price 11.6 |
Price to earnings Ratio - | 1Y Target Price 11.6 | ||
Volume (30-day avg) 32.9K shares | Beta - | 52 Weeks Range 2.47 - 40.95 | Updated Date 09/16/2026 |
52 Weeks Range 2.47 - 40.95 | Updated Date 09/16/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.36 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| QTscan Systems | Sale and leasing of QTscan breast imaging units. | The company makes money by selling or leasing its specialized medical imaging hardware. |
| Service & Software | Maintenance contracts, software updates, and clinical support services. | Recurring revenue is generated through servicing the installed base of machines. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 42.27M | Price to Sales(TTM) 1.42 |
Enterprise Value 42.27M | Price to Sales(TTM) 1.42 | ||
Enterprise Value to Revenue 1.6 | Enterprise Value to EBITDA -6.11 | Shares Outstanding 14.64M | Shares Floating 10.71M |
Shares Outstanding 14.64M | Shares Floating 10.71M | ||
Percent Insiders 26.95 | Percent Institutions 22.3 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About QT Imaging Holdings, Inc. Common Stock
Exchange NASDAQ | Headquarters Novato, CA, United States | ||
IPO Launch date 2021-11-04 | CEO & Director Dr. Raluca Dinu Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 31 | Website https://www.qtimaging.com |
Full time employees 31 | Website https://www.qtimaging.com | ||
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.